Stellanova Therapeutics is developing the first cancer therapies targeting cancer-associated fibroblasts (CAFs) and their symbiotic interactions within the tumor microenvironment.
Merck
350 followers
Swedish Algae Factory
3 followers
Apogee Therapeutics
2 followers
Cellares
6 followers
phagos
1 follower
Primmune Therapeutics
1 follower
Johnson & Johnson
678 followers
Assured
3 followers
Sanofi
489 followers
Thermo Fisher Scientific
288 followers
Genentech
227 followers
Gilead Sciences
216 followers